|
V49680
|
(R)-MLT-985 |
1832577-07-7 |
(R)-MLT-985 (compound 11) is a potent MALT1 protease inhibitor (antagonist) with IC50 of 3 nM. |
|
V44433
|
(R)-N-Fmoc-2-(4'-pentenyl)glycine |
1093645-21-6 |
(R)-N-Fmoc-2-(4'-pentenyl)glycine, derivative of glycine |
|
V37590
|
(R)-NVS-ZP7-4 |
|
(R)-NVS-ZP7-4, the R-isomer of NVS-ZP7-4, is a novel and potent Zinc transporter SLC39A7 (ZIP7) inhibitor that is also the first reported chemical tool to probe the impact of modulating ER zinc levels and investigate ZIP7 as a novel druggable node in the Notch pathway. |
|
V44404
|
(R)-Oxybutynin |
119618-21-2 |
(R)-Oxybutynin (Aroxybutynin), the racemic isomer of Oxybutynin, is an orally bioactive muscarinic receptor blocker (antagonist). |
|
V43978
|
(R)-RP-6306 |
2719793-91-4 |
(R)-RP-6306 may be utilized to study Myt1-mediated diseases and cancer types to slow cancer progression. |
|
V47461
|
(R)-SLV 319 |
656827-86-0 |
(R)-SLV 319 is a potent and specific cannabinoid receptor 1 (CB1) antagonist (inhibitor) with Ki of 894 nM. |
|
V48899
|
(R)-Stiripentol-d9 |
|
(R)-Stiripentol-d9 is the deuterium labelled form of (R)-Stiripentol. |
|
V43697
|
(R)-STU-104 |
2767124-77-4 |
(R)-STU104 is a potent and orally bioactive inhibitor of the protein interaction between TAK1 and MKK3, with IC50s of 0.58 μM and 4.0 μM for TNF-α and MKK3 phosphorylation, respectively. |
|
V48249
|
(R)-Timolol-d9 maleate |
|
(R)-Timolol-d9 (maleate) is the deuterium labelled form of (R)-Timolol (maleate). |
|
V37586
|
(R)-Trolox |
53101-49-8 |
(R)-Trolox, a water soluble vitamin E analog, is a potent and competitive tyrosinase inhibitor with a Ki value of 0.83 mM and a ID50 value of 1.88 mM. |
|
V48615
|
(R)-Zanubrutinib-d5 |
|
(R)-Zanubrutinib-d5 is the deuterium labelled form of (R)-Zanubrutinib. |
|
V43334
|
(R,1R)-Tenofovir amibufenamide (HS-10234) |
1571076-37-3 |
(R,1R)-Tenofovir amibufenamide ((R,1R)-HS-10234) may be utilized to purify tenofovir prodrugs. |
|
V50200
|
(R-)L-Felinine-d1 |
1976007-34-7 |
(R-)L-Felinine-d1, deuterium labeled 1-Pentadecanoyl-2-oleoyl-sn-glycero-3-phosphocholine |
|
V43403
|
(Rac)-1,2-Distearoyl-sn-Glycero-3-Phosphatidylglycerol sodium |
124011-52-5 |
(Rac)-1,2-Distearoyl-sn-Glycero-3-Phosphatidylglycerol (sodium) is an anionic phospholipid and can be used for drug delivery and liposome synthesis. |
|
V45365
|
(Rac)-16:0 PI(5)P-d5 ammonium |
2260669-80-3 |
(Rac)-16:0 PI(5)P-d5 (ammonium) is the deuterium labelled form of (Rac)-16:0 PI(5)P (ammonium). |
|
V45354
|
(Rac)-16:0PI(3,5)P2-d5 ammonium |
2260669-78-9 |
(Rac)-16:0PI(3,5)P2-d5 (ammonium) is the deuterium labelled form of (Rac)-16:0PI(3,5)P2 (ammonium). |
|
V46539
|
(Rac)-2-Aminobutyric acid-d3 |
1219373-19-9 |
(Rac)-2-Aminobutyric acid-d3 is the deuterium labelled form of Chlomethoxyfen. |
|
V46513
|
(Rac)-3-Aminoisobutyric acid-d3 HCl |
1346602-62-7 |
(Rac)-3-Aminoisobutyric acid-d3 (HCl) is the deuterium labelled form of DL-Histidine. |
|
V48734
|
(Rac)-4-Hydroxy Duloxetine-d3 |
|
(Rac)-4-Hydroxy Duloxetine-d3 is the deuterium labelled form of (Rac)-4-Hydroxy Duloxetine. |
|
V48873
|
(Rac)-Ambrisentan-d5 |
1392210-85-3 |
(Rac)-Ambrisentan-d5 is the deuterium labelled form of (Rac)-Ambrisentan. |